CN Patent

CN111647005A — 巴洛沙韦新晶型及其制备方法

Assigned to Anhui Haoyuan Pharmaceutical Co ltd · Expires 2020-09-11 · 6y expired

What this patent protects

本发明涉及多种巴洛沙韦(Baloxavir marboxil，式Ⅰ)的新晶型及其制备方法。与现有技术相比，本发明制备得到的新晶型具有溶解性好、引湿性小、工艺稳定、可操作性强、收率高、制备可重现性好，而且所得晶型稳定，适合医药开发等优点。

USPTO Abstract

本发明涉及多种巴洛沙韦(Baloxavir marboxil，式Ⅰ)的新晶型及其制备方法。与现有技术相比，本发明制备得到的新晶型具有溶解性好、引湿性小、工艺稳定、可操作性强、收率高、制备可重现性好，而且所得晶型稳定，适合医药开发等优点。

Drugs covered by this patent

Patent Metadata

Patent number
CN111647005A
Jurisdiction
CN
Classification
—
Expires
2020-09-11
Drug substance claim
No
Drug product claim
No
Assignee
Anhui Haoyuan Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.